Alzheimer Disease Familial
📧 Sign up to get email alerts when something new happens for Alzheimer Disease Familial.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease [Phase 3]
Phase 3 trial update for the DIAN-TU Amyloid Removal Trial in dominantly inherited Alzheimer's disease. The study status is ACTIVE_NOT_RECRU…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating potential disease-modifying treatments for early-onset Alzheimer's disease caused by a genetic muta…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) [Phase 2, Phase 3]
Clinical trial update for the DIAN-TU study, investigating disease-modifying therapies in individuals with dominantly inherited early-onset …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 [Phase 2, Phase 3]
DIAN-TU-001 is a master protocol investigating potential disease-modifying treatments for dominantly inherited Alzheimer's disease in indivi…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation [Phase 2, Phase 3]
The Dominantly Inherited Alzheimer Network Trial, studying potential disease-modifying treatments for individuals at risk for or with famili…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. [Phase 2, Phase 3]
A multicenter Phase 2/3 study evaluating potential disease-modifying treatments for individuals at risk for or with dominantly inherited ear…